Online-Only: Original Studies
Baxter, Roger MD*; Baine, Yaela PhD†; Ensor, Kathleen BA, RN*; Bianco, Veronique MS‡; Friedland, Leonard R. MD†; Miller, Jacqueline M. MD†
Author Information
From the *Kaiser Permanente Vaccine Study Center, Oakland, CA; †GlaxoSmithKline Biologicals, King of Prussia, PA; and ‡GlaxoSmithKline Biologicals, Wavre, Belgium.
Accepted for publication November 3, 2010.
Supported by GlaxoSmithKline Biologicals (109377/NCT00454909). GlaxoSmithKline was involved in all stages of the study conduct and analysis (ClinicalTrials.gov Identifier: 00454909). GlaxoSmithKline Biologicals also took in charge all costs associated with the development and publishing of the present manuscript. All authors had full access to the data. The corresponding author had final responsibility to submit for publication. The principal investigator for this study supported by GlaxoSmithKline Biologicals and has received grants from Novartis and Sanofi-Pasteur (to R.B.).
Authors Y.B., V.B., L.F., and J.M. are employees of GlaxoSmithKline Biologicals; Y.B., L.R.F., and J.M.M. report ownership of stock options.
Address for correspondence to: Roger Baxter, MD, 1 Kaiser Plaza, Ordway Building, Oakland, CA 94612. E-mail: [email protected].
doi: 10.1097/INF.0b013e3182054ab9
